Literature DB >> 21911603

T cell dynamics during induction of tolerance and suppression of experimental allergic encephalomyelitis.

Rohit D Divekar1, Cara L Haymaker, Jason A Cascio, Betul F Guloglu, Jason S Ellis, Danielle M Tartar, Christine M Hoeman, Craig L Franklin, Bernd H Zinselmeyer, Jennifer N Lynch, Mark J Miller, Habib Zaghouani.   

Abstract

The cell dynamics associated with induction of peripheral T cell tolerance remain largely undefined. In this study, an in vivo model was adapted to two-photon microscopy imaging, and T cell behavior was analyzed on tolerogen-induced modulation. FcγR-deficient (FcγR(-/-)) mice were unable to resist or alleviate experimental allergic encephalomyelitis when treated with Ig-myelin oligodendrocyte glycoprotein (MOG) tolerogen, an Ig carrying the MOG35-55 peptide. However, when FcγR(+/+) dendritic cells (DCs) are adoptively transferred into FcγR(-/-) mice, uptake and presentation of Ig-MOG occurs and the animals were able to overcome experimental allergic encephalomyelitis. We then fluorescently labeled FcγR(+/+) DCs and 2D2 MOG-specific TCR-transgenic T cells, transferred them into FcγR(-/-) mice, administered Ig-MOG, and analyzed both T cell-DC contact events and T cell motility. The results indicate that tolerance takes place in lymphoid organs, and surprisingly, the T cells do not become anergic but instead have a Th2 phenotype. The tolerant Th2 cells displayed reduced motility after tolerogen exposure similar to Th1 cells after immunization. However, the Th2 cells had higher migration speeds and took longer to exhibit changes in motility. Therefore, both Th1 immunity and Th2 tolerance alter T cell migration on Ag recognition, but the kinetics of this effect differ among the subsets.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911603      PMCID: PMC3186833          DOI: 10.4049/jimmunol.1100531

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  The enemy within: keeping self-reactive T cells at bay in the periphery.

Authors:  Lucy S K Walker; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.

Authors:  Mark J Miller; Sindy H Wei; Ian Parker; Michael D Cahalan
Journal:  Science       Date:  2002-05-16       Impact factor: 47.728

3.  Dynamic imaging of T cell-dendritic cell interactions in lymph nodes.

Authors:  Sabine Stoll; Jérôme Delon; Tilmann M Brotz; Ronald N Germain
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

4.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

5.  T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node.

Authors:  Mark J Miller; Arsalan S Hejazi; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-13       Impact factor: 11.205

6.  IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2.

Authors:  Lequn Li; Hyun-Hee Lee; J Jeremiah Bell; Randal K Gregg; Jason S Ellis; Andre Gessner; Habib Zaghouani
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis.

Authors:  K L Legge; B Min; J J Bell; J C Caprio; L Li; R K Gregg; H Zaghouani
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity.

Authors:  Kevin L Legge; Randal K Gregg; Roberto Maldonado-Lopez; Lequn Li; Jacque C Caprio; Muriel Moser; Habib Zaghouani
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  11 in total

1.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

2.  Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se.

Authors:  Yan Su; Robert Rossi; Anne S De Groot; David W Scott
Journal:  J Leukoc Biol       Date:  2013-05-31       Impact factor: 4.962

3.  IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.

Authors:  Subhasis Barik; Jason S Ellis; Jason A Cascio; Mindy M Miller; Tobechukwu K Ukah; Alexis N Cattin-Roy; Habib Zaghouani
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

Review 4.  Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging.

Authors:  Jordan Jacobelli; Alan E Buser; Dustin L Heiden; Rachel S Friedman
Journal:  Immunol Rev       Date:  2021-11-25       Impact factor: 10.983

5.  In trans T cell tolerance exacerbates experimental allergic encephalomyelitis by interfering with protective antibody responses.

Authors:  Jason A Cascio; Marie-Therese Khairallah; Xiaoxiao Wan; Weirong Chen; Linda M Rowland; Mermagya Dhakal; Mindy M Miller; Habib Zaghouani
Journal:  J Neuroimmunol       Date:  2013-10-05       Impact factor: 3.478

Review 6.  Peripheral tolerance and autoimmunity: lessons from in vivo imaging.

Authors:  Jordan Jacobelli; Robin S Lindsay; Rachel S Friedman
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

7.  Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.

Authors:  Mark D Mannie; J Lori Blanchfield; S M Touhidul Islam; Derek J Abbott
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

8.  Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.

Authors:  Fernanda Chiuso-Minicucci; Larissa Lumi Watanabe Ishikawa; Luiza Ayumi Nishiyama Mimura; Thais Fernanda de Campos Fraga-Silva; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Camila Marques; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

9.  Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.

Authors:  Patricia J McLaughlin; Daniel P McHugh; Marcus J Magister; Ian S Zagon
Journal:  BMC Immunol       Date:  2015-04-24       Impact factor: 3.615

Review 10.  Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis.

Authors:  Barbara Rossi; Gabriela Constantin
Journal:  Front Immunol       Date:  2016-11-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.